Navigation Links
LifeCare Holdings, Inc. Announces Year-end Results
Date:3/28/2008

%

2006 2007 Change

Net patient service revenue $79,868 $79,739 -0.2%

Expenses:

Salaries, wages and benefits 36,765 38,521 4.8%

Supplies 7,281 8,509 16.9%

Rent 4,541 5,953 31.1%

Other operating expense 17,087 16,970 -0.7%

Provision for doubtful accounts 3,385 453 -86.6%

Depreciation and amortization 3,054 2,570 -15.8%

Goodwill impairment charges 19,000 35,000 84.2%

Long-lived asset impairment charges 945 - NM

Interest expense, net 8,234 9,445 14.7%

100,292 117,421 17.1%

Operating loss (20,424) (37,682) 84.5%

Equity in loss of joint venture - (246) NM

Loss before income taxes (20,424) (37,928) 85.7%

Provision for (benefit from) income

taxes (802) 2,729 -440.3%

Net loss $(19,622) $(40,657) 107.2%

Reconciliation to Credit Agreement

EBITDA:

Operating loss - per above $(20,424) $(37,682)

Adjusted for:

Interest expense, net 8,234 9,445

Depreciation and amortization 3,054 2,570

Goodwill impairment charges 19,000 35,000

Stock compensation expense 164 169

Cost saving initiatives - 320

Hospital closure/reloca
'/>"/>

SOURCE LifeCare Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine news :

1. LifeCare Hospitals of Wisconsin Unveils Center for Advanced Wound Healing
2. LifeCare Holdings, Inc. Announces Third Quarter Results
3. Batesville Holdings, Inc., Appoints Doug Wilson Senior Vice President Human Resources
4. Previously Disclosed Changes in Board Composition of NightHawk Radiology Holdings, Inc. Prompt Notice of Noncompliance from the Nasdaq Global Market
5. Solera Holdings, Inc. Appoints Jason Brady as General Counsel
6. Duane Reade Holdings, Inc. to Report Fourth Quarter and Full Year 2007 Financial Results
7. Whitemark Homes Signs Letter of Intent to Acquire Metiscan Holdings, Inc.
8. Vallon Holdings, LLC Launches New Subsidiary Focused on Contract Resources for the Minneapolis-St. Paul Life Science Industry
9. NightHawk Radiology Holdings, Inc. Announces Board Member Departure
10. NightHawk Radiology Holdings, Inc. to Speak at the Cowen and Company 28th Annual Health Care Conference on March 18, 2008
11. Lixte Biotechnology Holdings, Inc. Announces Further Developments Regarding the Anti-Cancer Activity of Its Patent-Pending Proprietary Compounds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2008)...to Historic Low as Pharma Companies Face ...ONDON, July 24 /PRNewswire/ -- The Scientific busi...bility of the newly published CMR,International 20...eference,and business planning tool for decision m...siness strategy, marketing planning and corporate,...
(Date:7/23/2008)...ke Forest University Baptist Medical Center demons...fying patients who are having a heart attack, even..., The study used data from a registry called i*tr...oms who were admitted to emergency departments (ED...indings were released today in the Emergency Medi...
(Date:7/23/2008)... July 23 /PRNewswire-FirstCall/ - Cardiome Pharma ... it has entered into an,agreement with CR Intrinsi...CR Intrinsic Investors, LLC, an affiliate of S.A.C...rtible preferred shares for gross proceeds of,US$2...for general corporate,purposes, costs associated w...
(Date:7/23/2008)...ll/ -- The Hanover Insurance Group,a leading supe...nounced it,is prepared to respond to claims result...h southern Texas today., (Logo: http://www.newsc...re deeply concerned about individuals and business...t of The Hanover,s Central Region. "Our,staff is s...
Breaking Medicine News(10 mins):Health News:Thomson Reuters Publishes CMR International's 2008 Pharmaceutical R&D Factbook, Now Available for the First Time Online 2Health News:Study shows emergency physicians have good first instincts in diagnosing heart attacks 2Health News:Cardiome Announces Preferred Share Financing 2Health News:Cardiome Announces Preferred Share Financing 3Health News:The Hanover Ready to Serve Policyholders Impacted by Hurricane Dolly 2
...nsplant surgery was conducted through which 3-mont...e Kayla Richardson, a 12 week old baby received a ...ble as a baby in another state passed away, and it...bies who were in need of the transplants. The de...
...ht, an immunologist at the U.S. Centers for Diseas...seasonal influenza virus this year have developed ...hich is used for the treatment for flu infection. ...tadine and rimantadine are ineffectual for now and...
...Africa is a country worst hit by AIDS. But now aft...y limiting the number of partners, delaying the i...ed the number of people suffering from AIDS in tha...men in the age group of 15-24 the prevalence of AI...
...rus doesn’t seem to rest in the Asian peninsula. A... for bird flu has died at Hasan Sadikin Hospital i...ocal results are verified by the WHO -accredited l...ome the 15th human fatality from bird flu in Indon...
Other Medicine News:Health News:Resistant Influenza strains creates panic in US 2
(Date:7/22/2008)...NE, Australia, July 22 /- F...terday, the Board of Progen,Pharmaceuticals Limite...,had discontinued the PI-88 phase 3 study in liver...to develop its existing portfolio of compounds and...nal compounds and,opportunities through Merger & A...
(Date:7/22/2008)...POLIS, July 22 /- Nonin Medical, a le...ons for more than 20 years, has entered,the clinic...to measure,regional oxygen saturation. Today,s mos...ntinuous monitoring of the regional blood oxygenat...ting data and outcomes from an ongoing clinical st...
(Date:7/22/2008)... Meeting to Discuss Development Plan Completed Suc...irstCall/ -- Amarin Corporation,plc (NASDAQ: AMRN...ith,officials at the U.S. Food and Drug Administra...op AMR101 for the treatment of,hypertriglyceridemi...ceeding to Phase 3 with AMR101 in hypertriglycerid...
(Date:7/22/2008)...f-the-Art PET Study Confirms Tyrima Exhibits Excel...ties - - Results Support Initiation of Phase...C., July 22 /- CeNeRx BioPharma,Inc....alizing innovative,treatments for diseases of the ...dvance its lead candidate Tyrima(TM) into Phase II...
Breaking Medicine Technology:Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 2Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 3Nonin Medical Inc. Announces Entry Into the Cerebral Oximeter Market 2Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 2Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 3CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 2CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 3CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 4Rodent fossils allows to determine climate of the Iberian Peninsula 6 million years ago 1376 1Rodent fossils allows to determine climate of the Iberian Peninsula 6 million years ago 1376 2Getty Images Celebrates Conclusion of Change Me Imagery Forum 941 1Getty Images Celebrates Conclusion of Change Me Imagery Forum 941 2Getty Images Celebrates Conclusion of Change Me Imagery Forum 941 3Voices to Unite in Los Angeles for 6 000 Children Orphaned Daily 938 1Voices to Unite in Los Angeles for 6 000 Children Orphaned Daily 938 2SLIM Search Launches Academic Pricing Program 1373 1SLIM Search Launches Academic Pricing Program 1373 2
Blumenthal Bone Rongeur
Beyer Bone Rongeur
Rongeur #18
Rongeur #267
Medicine Products: